The Translational Genomics Research Institute
The Translational Genomics Research Institute reported $75.9 million in revenue and $86.3 million in expenses for the fiscal year ending September 30, 2025. Of every $100 it spent, $70.57 went to program services, $29.43 to management and general costs and $0.00 to fundraising. Its largest source of revenue was contributions and grants: 55.5% of the total. Government grants made up 37.8%. The highest compensation it reported for one person was $7,115,857 (BD & VICE CHRM/COH CEO & PRES.). 122 people received more than $100,000 in reportable compensation. Revenue rose 2% between FY2020 and FY2025. Source: Form 990, FY2025.
Where $100 of spending went
The fiscal year ending September 30, 2025 · Form 990, Part IX, line 25 · total expenses $86MFor context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
The fiscal year ending September 30, 2025 · Form 990, Part VIII · total revenue $76M- Contributions & grants (non-government)$16.77 $13M
- Government grants$35.85 $29M
- Program service revenue$43.98 $35M
- Investment income$3.40 $2.7M
Other revenue was negative: −$4.1M. The bar shows the positive sources only.
The 990 scorecard · same measures for every charity, no grades
| Measure | FY2025 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 70.6% | 83.9% |
| Management & general Part IX 25(C) ÷ 25(A) | 29.4% | 12.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.0% | 0.1% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.00 | $0.01 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 55.5% | 72.7% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 37.8% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 46.4% | 5.8% |
| Highest reported compensation Part VII-A, columns D–F | $7,115,857 | $628,890 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 8.25% | 1.94% |
| People paid over $100,000 Part VII, line 2 | 122 | 18 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 12.0 | 13.3 |
| Independent voting board members Part VI 1a–1b | 10 of 12 | 93.8% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
FY2025 · Form 990, Part III · the three largest programs by expenseHighest reported compensation
FY2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| BD & VICE CHRM/COH CEO & PRES. Director/trustee, officer, 1.0 hrs/week | $0 | $6,085,650 | $1,030,207 | $7,115,857 |
| BOARD MEMBER/PRES/SCIENCE DIR. Director/trustee, officer, 39.0 hrs/week | $0 | $1,780,335 | $250,930 | $2,031,265 |
| SECRETARY/COH GENERAL COUNSEL Officer, 1.0 hrs/week | $0 | $1,355,050 | $250,967 | $1,606,017 |
| TREASURER/COH CFO (PT YR) Former, 0.0 hrs/week | $0 | $1,211,996 | $38,027 | $1,250,023 |
| TGEN DISTINGUISHED PROFESSOR AND EXECUTIVE VICE PRESIDENT, MOLECULAR MEDICINE DI Key employee, 40.0 hrs/week | $1,004,466 | $0 | $24,010 | $1,028,476 |
| CHIEF OPERATING OFFICER Officer, 39.0 hrs/week | $873,875 | $0 | $78,630 | $952,505 |
| COH CHIEF FINANCIAL OFFICER, TREASURER Officer, 1.0 hrs/week | $0 | $864,143 | $88,040 | $952,183 |
| PHYSICIAN IN CHIEF Key employee, 40.0 hrs/week | $612,635 | $0 | $32,391 | $645,026 |
122 people received more than $100,000 in reportable compensation from The Translational Genomics Research Institute (Part VII, line 2). Compensation of current officers, directors and key employees totaled $5.0M (Part IX, line 5).
6 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
FY2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b12 · 10 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4Yes
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 5406
- Volunteers Part I, line 670
Largest outside contractors
FY2025 · Form 990, Part VII, Section B · businesses only| ERNST & YOUNG US LLP Professional services | $317,237 |
| FIRSTSTRATEGIC LLC Consulting services | $216,000 |
| IT CONVERGENCE Consulting services | $181,784 |
| GIRIKON Consulting services | $175,568 |
| PROTOS SOFTWARE LLC Consulting services | $174,623 |
Individuals listed as contractors are left out. 6 contractors were paid more than $100,000 in all.
Private foundation grants it received
7 private foundations reported grants to The Translational Genomics Research Institute totaling $416K on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.
Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.
Correct a figure or respond
Every number above is copied from The Translational Genomics Research Institute's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for The Translational Genomics Research Institute, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 The Translational Genomics Research Institute spent in FY2025, $70.57 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- Texas Biomedical Research InstituteSan Antonio, TX · revenue $75M · programs 54.7% · 2024
- The Wistar Institute of Anatomy and BiologyPhiladelphia, PA · revenue $77M · programs 79.2% · 2025
- Northern California Institute for Research and EducationSan Francisco, CA · revenue $69M · programs 84.4% · FY2025
- Foundation for the National Institutes of HealthNorth Bethesda, MD · revenue $79M · programs 85.7% · 2024
- Cardiovascular Research FoundationNew York, NY · revenue $69M · programs 87.5% · 2024
All medical research charities · Largest charities in Arizona
Questions people ask
How much of The Translational Genomics Research Institute's spending goes to programs?
In the fiscal year ending September 30, 2025, The Translational Genomics Research Institute reported that 70.6% of its $86.3 million in expenses went to program services, 29.4% to management and general and 0.0% to fundraising (Form 990, Part IX).
How much does The Translational Genomics Research Institute pay its top executive?
The largest total compensation The Translational Genomics Research Institute reported for one person in the fiscal year ending September 30, 2025 was $7,115,857, for the role of BD & VICE CHRM/COH CEO & PRES. (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does The Translational Genomics Research Institute get its money?
Of $75.9 million in revenue in the fiscal year ending September 30, 2025, 55.5% came from contributions and grants (including 37.8% from government grants) and 46.4% from program service revenue (Form 990, Part VIII).
Is The Translational Genomics Research Institute a registered charity?
The IRS lists EIN 75-3065445 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- FY2025: Form 990 for the fiscal year ending September 30, 2025, object 202612259349301821 · read the filing
- FY2024: Form 990 for the fiscal year ending September 30, 2024, object 202522269349300102 · read the filing
- FY2023: Form 990 for the fiscal year ending September 30, 2023, object 202432269349302118 · read the filing
- FY2022: Form 990 for the fiscal year ending September 30, 2022, object 202332269349302983 · read the filing
- FY2021: Form 990 for the fiscal year ending September 30, 2021, object 202232209349302003 · read the filing
- FY2020: Form 990 for the fiscal year ending September 30, 2020, object 202102249349301895 · read the filing
All filings for EIN 75-3065445: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.